Monash leads world-first trial of cholesterol-lowering gene-editing therapy

The Victorian Heart Hospital and Victorian Heart Institute, operated by Monash Health in partnership with Monash University, have led a groundbreaking first-in-human trial of a gene-editing therapy that could permanently lower cholesterol and triglyceride levels in people with difficult-to-treat lipid disorders. …